Projects and Grants per year
Personal profile
Research Interests
Phase I investigations, lung cancer, head and neck cancer, radiation-chemotherapy interactions, population studies in Appalachia.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Post Doctoral Fellow, University Of Kentucky
1998
Doctor of Medicine, University Of Kentucky
1992
Bachelor of Arts, Brown University
1985
Residency, University Of Virginia
1985
Fingerprint
Dive into the research topics where Susanne Arnold is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
-
24-HN-40-MSD (007-00): A Phase 2/3, Adaptive, Randomized, Open-Label, Clinical Study to Evaluate Neoadjuvant and Adjuvant V940 (mRNA-4157) in Combination with Pembrolizumab (MK- 3475) Versus Standard of Care, and Pembrolizumab Monotherapy in Participants
Arnold, S. (PI)
Merck Sharp & Dohme Corporation
9/3/24 → 9/3/26
Project: Research project
-
23-LUN-135-EL (J3M-MC-JZQB): A Global Pivotal Study in Participants with KRAS G12C-Mutant, Locally Advanced or Metastatic Non-Small Cell Lung Cancer Comparing First- Line Treatment of LY3537982 and Pembrolizumab vs Placebo and Pembrolizumab in Those with
Arnold, S. (PI)
5/6/24 → 5/6/26
Project: Research project
-
Personnel Costs: The Experimental Therapeutics Clinical Trials Network
Arnold, S. (PI), Gabriel, G. (CoI), Myint, Z. (CoI), Chauhan, A. (Former CoI), Kolesar, J. (Former CoI) & Kunos, C. (Former CoI)
3/1/24 → 2/28/26
Project: Research project
-
A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients with Small Cell Lung Cancer
Morgensztern, D., Ready, N., Johnson, M. L., Dowlati, A., Choudhury, N., Carbone, D. P., Schaefer, E., Arnold, S. M., Puri, S., Piotrowska, Z., Hegde, A., Chiang, A. C., Iams, W., Tolcher, A., Nosaki, K., Kozuki, T., Li, T., Santana-Davila, R., Akamatsu, H. & Murakami, H. & 8 others, , Nov 15 2024, In: Clinical Cancer Research. 30, 22, p. 5042-5052 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A Probabilistic Approach to Estimate the Temporal Order of Pathway Mutations Accounting for Intra-Tumor Heterogeneity
Wang, M., Xie, Y., Liu, J., Li, A., Chen, L., Stromberg, A., Arnold, S. M., Liu, C. & Wang, C., Jul 2024, In: Cancers. 16, 13, 2488.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis
The International Lung Cancer Consortium & The PRACTICAL Consortium, Feb 2024, In: EBioMedicine. 100, 104991.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Cancer research provides a model for advancing clinical trials in dementia in the era of disease-modifying Alzheimer’s-type dementia therapies
Jicha, G. A., Tucker, T. C., Arnold, S. M. & Nelson, P. T., Dec 2024, In: Alzheimer's Research and Therapy. 16, 1, 184.Research output: Contribution to journal › Review article › peer-review
Open Access -
CYP2A6 Activity and Cigarette Consumption Interact in Smoking-Related Lung Cancer Susceptibility
Du, M., Xin, J., Zheng, R., Yuan, Q., Wang, Z., Liu, H., Liu, H., Cai, G., Albanes, D., Lam, S., Tardon, A., Chen, C., Bojesen, S. E., Landi, M. T., Johansson, M., Risch, A., Bickeboller, H., Wichmann, H. E., Rennert, G. & Arnold, S. & 25 others, , 2024, In: Cancer Research. 84, 4, p. 616-625 10 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations